abstract |
The invention belongs to the field of medicinal chemistry, and particularly relates to an FGFR4 inhibitor shown in a formula II, a preparation method thereof, a pharmaceutical composition containing the inhibitor, and application of the inhibitor or the pharmaceutical composition as a tumor treatment medicament. |